Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 24;60(9):1387.
doi: 10.3390/medicina60091387.

Anti-Müllerian Hormone Level Determinants among Non-Polycystic-Ovary-Syndrome Women Undergoing In Vitro Fertilization: A Retrospective Cross-Sectional Study

Affiliations

Anti-Müllerian Hormone Level Determinants among Non-Polycystic-Ovary-Syndrome Women Undergoing In Vitro Fertilization: A Retrospective Cross-Sectional Study

Melinda Kolcsar et al. Medicina (Kaunas). .

Abstract

Background and Objectives: The anti-Müllerian hormone (AMH) is a crucial biomarker in regulating ovarian follicle development and female fertility. AMH levels predict ovarian responses in in vitro fertilization (IVF) cycles, helping clinicians tailor treatment strategies. This study aims to determine whether thyroid autoimmunity, age, body mass index (BMI), sexual hormone levels, and 25-hydroxyvitamin D levels influence serum AMH in non-polycystic-ovary-syndrome (PCOS) euthyroid women. Materials and Methods: This retrospective cross-sectional study examined 52 female patients at Zygota Fertility Clinic between 2018 and 2022. Women aged 20-45 years with regular menstrual cycles were included, while conditions such as abnormal thyroid-stimulating hormone (TSH) levels, PCOS, and systemic autoimmune diseases were excluded. A number of parameters were measured in the study, including the subjects' age, BMI, 25-hydroxyvitamin D, serum free thyroxine (fT4), TSH, various antibodies, and a range of reproductive hormones. An analysis of the relationships between AMH and other variables was conducted using Spearman's correlation coefficient, and an assessment of the impact of confounding factors on AMH levels was conducted using a multivariable linear regression model. Results: The results revealed significant negative correlations between AMH levels and age (rho: -0.484, p < 0.001) and follicle-stimulating hormone (FSH) (rho: -0.550, p < 0.001), while positive correlations existed between AMH and estradiol (rho: 0.352, p = 0.011) and total testosterone (rho: 0.542, p < 0.001). No significant correlations were found between AMH levels and BMI, LH, or 25-hydroxyvitamin D. Conclusions: In this study, ovarian reserve was influenced by age, estradiol, and total testosterone in non-PCOS euthyroid women undergoing IVF. Conversely, BMI and vitamin D status did not significantly impact AMH levels. In order to better understand and possibly manage ovarian reserve, a holistic approach is absolutely essential, taking into account age, weight, hormonal balance, nutrition, and thyroid health.

Keywords: 25-hydroxivitamin D; age; anti-Müllerian hormone; autoimmune thyroiditis; body mass index; sexual hormones; thyroid hormones.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Figures

Figure 1
Figure 1
The relationship between clinical–biochemical parameters and AMH level. (a) Age and AMH correlation, (b) BMI and AMH correlation, (c) progesterone and AMH correlation, (d) estradiol and AMH correlation, (e) LH and AMH level correlation, (f) FSH and AMH level correlation, (g) testosterone and AMH level correlation, (h) TSH and AMH level correlation, (i) fT4 and AMH level correlation, and (j) AMH and 25-hydroxyvidamin D level correlation. BMI—body mass index; AMH—anti-Müllerian hormone; LH—luteinizing hormone; FSH—follicle-stimulating hormone; TSH—thyroid-stimulating hormone; fT4—free thyroxine; rho—Spearman’s correlation coefficient.

References

    1. McLennan I.S., Pankhurst M.W. Anti-Müllerian Hormone Is a Gonadal Cytokine with Two Circulating Forms and Cryptic Actions. J. Endocrinol. 2015;226:R45–R57. doi: 10.1530/JOE-15-0206. - DOI - PubMed
    1. Broekmans F.J., Kwee J., Hendriks D.J., Mol B.W.J., Lambalk C.B. A Systematic Review of Tests Predicting Ovarian Reserve and IVF Outcome. Hum. Reprod. Update. 2006;12:685–718. doi: 10.1093/humupd/dml034. - DOI - PubMed
    1. Oh S.J., Choe S.Y., Cho Y.J. Clinical Application of Serum Anti-Müllerian Hormone in Women. Clin. Exp. Reprod. Med. 2019;46:50–59. doi: 10.5653/cerm.2019.46.2.50. - DOI - PMC - PubMed
    1. Robertson D. Predictors of IVF Outcome: Markers and Protocols. Women Health. 2006;2:385–388. doi: 10.2217/17455057.2.3.385. - DOI - PubMed
    1. Umarsingh S., Adam J.K., Krishna S. The Relationship Between Anti-Müllerian Hormone (AMH) Levels and Pregnancy Outcomes in Patients Undergoing Assisted Reproductive Techniques (ART) Peerj. 2020;8:e10390. doi: 10.7717/peerj.10390. - DOI - PMC - PubMed

LinkOut - more resources